Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Outcomes Primary outcome measures were selected based on available vital and lab measurements that would capture the intended impact of GLP-1s especially for diabetic or obese patients, as at the time of this study, GLP-1 use had primarily been approved as therapy to improve glycemic control and support weight loss
People with a severe infection may require a longer course of antibiotics
Photograph of DiMarchi, credit: Indiana University
designed and expressed four injectable long-acting GLP-1R agonists in a bacterial expression system by genetically fusing Exendin-4 to the N-terminus of HSA-binding DARPin via linkers of different types and lengths
US$ 20.26
US$ 24.24
US$ 20.54
US$ 25.17
US$ 25.98
US$ 21.65
US$ 28.71
US$ 23.03
